What the PSA Test Actually Measures
The prostate-specific antigen (PSA) test is a blood test that measures the level of PSA — a protein produced by both normal and abnormal prostate cells — in your bloodstream. It's one of the most commonly ordered tests in men's preventive care, yet it's also one of the most frequently misunderstood.
PSA is not a cancer marker in the way many men assume. The prostate naturally releases small amounts of PSA into the blood, and that amount tends to increase with age even in healthy men. What the test detects is elevation — a level above a general threshold — which prompts further investigation, not a diagnosis.
For broader context on how the prostate changes across a man's life, see Prostate Health Across the Decades.
Myth
A high PSA result means you have prostate cancer.
Fact
Elevated PSA can result from several benign conditions and does not confirm a cancer diagnosis.
PSA levels can rise due to benign prostatic hyperplasia (BPH — non-cancerous enlargement of the prostate), prostatitis (inflammation or infection), vigorous physical activity, or even recent ejaculation. A single elevated reading is a signal to investigate further, typically with a repeat test, imaging, or biopsy — not a diagnosis in itself. Only a tissue biopsy can confirm prostate cancer.
Myth
A normal PSA result rules out prostate cancer entirely.
Fact
Prostate cancer can be present even when PSA levels fall within the normal range.
PSA screening has a meaningful false-negative rate. Some aggressive prostate cancers produce relatively little PSA, and certain medications used to treat BPH can artificially lower PSA readings. A normal result reduces suspicion but does not eliminate it. If symptoms or other risk factors are present, further evaluation may still be warranted regardless of PSA level.
Myth
PSA testing is a routine test every man should get annually after 50.
Fact
PSA screening is not universally recommended; guidelines emphasize shared decision-making over automatic annual testing.
Guidelines from organizations such as the American Cancer Society recommend that men discuss the potential benefits and harms of PSA testing with their doctor before deciding whether to screen. Age, overall health, life expectancy, family history, and race all factor into that conversation. Routine annual testing without this context can lead to overdiagnosis and unnecessary treatment of cancers that may never cause harm.
Myth
PSA testing is only relevant for older men.
Fact
For men with elevated risk factors, screening conversations should begin as early as age 40.
Black men have roughly double the incidence rate of prostate cancer compared to white men in the U.S., and men with a first-degree relative who had prostate cancer — especially before age 65 — face a significantly higher lifetime risk. Clinical guidance suggests these men discuss screening earlier, not waiting until the standard age-50 threshold. Genetics and family history are important variables that shift the calculus on when to start.
Myth
A biopsy is always the next step after an elevated PSA.
Fact
Several intermediate steps — including repeat testing, imaging, and risk calculators — are typically considered before proceeding to biopsy.
Urologists increasingly use multiparametric MRI (mpMRI) of the prostate and secondary biomarker tests (such as the 4Kscore or PHI test) to refine risk assessment after an elevated PSA before recommending biopsy. This layered approach helps avoid unnecessary invasive procedures, which carry their own small risks including infection and bleeding. An elevated PSA initiates a diagnostic conversation, not an automatic procedural chain.
Why Screening Decisions Are Rarely Straightforward
Major medical organizations — including the U.S. Preventive Services Task Force and the American Cancer Society — do not recommend universal PSA screening for all men. Instead, they advocate for individualized decision-making, weighing potential benefits against the real risks of overdiagnosis and overtreatment.
~1 in 8
Lifetime risk of prostate cancer diagnosis in U.S. men
According to the American Cancer Society, prostate cancer is the most commonly diagnosed non-skin cancer in American men.
Up to 75%
PSA elevations that are not due to cancer
Research consistently shows the majority of elevated PSA results in screened populations are attributable to benign conditions rather than malignancy.
2x
Higher prostate cancer incidence in Black men vs. white men
The American Cancer Society reports Black men in the U.S. are about twice as likely to be diagnosed with and die from prostate cancer.
Overdiagnosis occurs when screening detects cancers that would never have caused symptoms or shortened a man's life. Treatment for these cancers — surgery, radiation, hormone therapy — carries its own serious side effects, including urinary incontinence and sexual dysfunction. Understanding this trade-off is essential to any informed screening conversation.
PSA Testing Is a Tool, Not a Verdict
No single PSA result should be interpreted in isolation. Results must be considered alongside your age, prostate size, medication use, symptoms, and personal risk factors. Before agreeing to — or declining — PSA screening, have a direct conversation with your doctor about what a positive or negative result would actually mean for you and what follow-up steps would look like.
Men at elevated risk — including Black men, who face disproportionately higher rates of prostate cancer incidence and mortality, and those with a first-degree relative diagnosed with prostate cancer before age 65 — are generally advised to start screening discussions earlier, around age 40 to 45. For average-risk men, age 50 is the common starting point for that conversation.
This article is for general informational purposes only and does not constitute medical advice. Speak with a qualified healthcare provider about your individual screening needs and risk factors.
The content on this site is for informational purposes only and is not a substitute for professional advice. Always consult a qualified professional for guidance specific to your situation.